Skip to main content
Top
Published in: Obesity Surgery 12/2014

01-12-2014 | Original Contributions

Acute Pancreatitis in Patients After Bariatric Surgery: Incidence, Outcomes, and Risk Factors

Authors: Arthi Kumaravel, Andrea Zelisko, Philip Schauer, Rocio Lopez, Matthew Kroh, Tyler Stevens

Published in: Obesity Surgery | Issue 12/2014

Login to get access

Abstract

Background

The incidence of acute pancreatitis (AP) in bariatric surgery patients is not known. Ouraim was to determine the incidence, outcomes, and risk factors of AP in post-bariatric surgery patients.

Methods

An historical cohort study was conducted of all patients who underwent Roux-en-Y gastric bypass, sleeve gastrectomy, adjustable gastric banding, and revisional procedures at our institution from January 2004 to September 2011. Patients who developed AP were identified by review of the electronic medical record. A nested case-control study using Cox regression analysis was done to identify risk factors.

Results

A total of 2695 patients underwent bariatric surgery. Twenty-eight patients (1.04 %) developed AP during a median follow-up of 3.5 years (interquartile range [IQR] 1.9–5.8). One patient had severe AP, and there was one AP-related death. In the case-control study, the only baseline variable that predicted post-operative AP was a prior history of AP. Three other variables identified after surgery were associated with AP: (1) rapid weight loss as measured by percent of excess weight loss (EWL) at the first post-operative visit, (2) abnormal findings on post-operative ultrasound (stones, sludge or ductal dilation), and (3) post-operative complications of bowel leak or anastomotic stricture.

Conclusions

The incidence of AP in this cohort is 1.04 %, which is higher than that reported for the general population (~17/100,000, 0.017 %). Most cases were clinically mild and managed conservatively with good outcomes. Rapid post-operative weight loss and the presence of gallstones or sludge on post-operative ultrasound were significant risk factors for AP.
Literature
1.
go back to reference Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults,–2010. JAMA. 2012;307(5):491–7.PubMedCrossRef Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults,–2010. JAMA. 2012;307(5):491–7.PubMedCrossRef
2.
go back to reference Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213(2):261–6.PubMedCrossRef Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003–2008. J Am Coll Surg. 2011;213(2):261–6.PubMedCrossRef
3.
go back to reference Bertin PM, Singh K, Arregui ME. Laparoscopic transgastric endoscopic retrograde cholangiopancreatography (ERCP) after gastric bypass: case series and a description of technique. Surg Endosc. 2011;25(8):2592–6.PubMedCrossRef Bertin PM, Singh K, Arregui ME. Laparoscopic transgastric endoscopic retrograde cholangiopancreatography (ERCP) after gastric bypass: case series and a description of technique. Surg Endosc. 2011;25(8):2592–6.PubMedCrossRef
4.
go back to reference Emmett DS, Mallat DB. Double-balloon ERCP in patients who have undergone roux-en-Y surgery: a case series. Gastrointest Endosc. 2007;66(5):1038–41.PubMedCrossRef Emmett DS, Mallat DB. Double-balloon ERCP in patients who have undergone roux-en-Y surgery: a case series. Gastrointest Endosc. 2007;66(5):1038–41.PubMedCrossRef
5.
go back to reference Falcao M, Campos JM, Neto MG, et al. Transgastric endoscopic retrograde cholangiopancreatography for the management of biliary tract disease after roux-en-Y gastric bypass treatment for obesity. Obes Surg. 2012;22(6):872–6.PubMedCrossRef Falcao M, Campos JM, Neto MG, et al. Transgastric endoscopic retrograde cholangiopancreatography for the management of biliary tract disease after roux-en-Y gastric bypass treatment for obesity. Obes Surg. 2012;22(6):872–6.PubMedCrossRef
6.
go back to reference Lopes TL, Clements RH, Wilcox CM. Laparoscopy-assisted ERCP: experience of a high-volume bariatric surgery center (with video). Gastrointest Endosc. 2009;70(6):1254–9.PubMedCrossRef Lopes TL, Clements RH, Wilcox CM. Laparoscopy-assisted ERCP: experience of a high-volume bariatric surgery center (with video). Gastrointest Endosc. 2009;70(6):1254–9.PubMedCrossRef
7.
go back to reference Patel JA, Patel NA, Shinde T, et al. Endoscopic retrograde cholangiopancreatography after laparoscopic roux-en-Y gastric bypass: a case series and review of the literature. Am Surg. 2008;74(8):689,93. discussion 693–4. Patel JA, Patel NA, Shinde T, et al. Endoscopic retrograde cholangiopancreatography after laparoscopic roux-en-Y gastric bypass: a case series and review of the literature. Am Surg. 2008;74(8):689,93. discussion 693–4.
8.
go back to reference Schreiner MA, Chang L, Gluck M, et al. Laparoscopy-assisted versus balloon enteroscopy-assisted ERCP in bariatric post-roux-en-Y gastric bypass patients. Gastrointest Endosc. 2012;75(4):748–56.PubMedCrossRef Schreiner MA, Chang L, Gluck M, et al. Laparoscopy-assisted versus balloon enteroscopy-assisted ERCP in bariatric post-roux-en-Y gastric bypass patients. Gastrointest Endosc. 2012;75(4):748–56.PubMedCrossRef
9.
go back to reference Tekola B, Wang AY, Ramanath M, et al. Percutaneous gastrostomy tube placement to perform transgastrostomy endoscopic retrograde cholangiopancreaticography in patients with roux-en-Y anatomy. Dig Dis Sci. 2011;56(11):3364–9.PubMedCrossRef Tekola B, Wang AY, Ramanath M, et al. Percutaneous gastrostomy tube placement to perform transgastrostomy endoscopic retrograde cholangiopancreaticography in patients with roux-en-Y anatomy. Dig Dis Sci. 2011;56(11):3364–9.PubMedCrossRef
10.
go back to reference Wright BE, Cass OW, Freeman ML. ERCP in patients with long-limb roux-en-Y gastrojejunostomy and intact papilla. Gastrointest Endosc. 2002;56(2):225–32.PubMedCrossRef Wright BE, Cass OW, Freeman ML. ERCP in patients with long-limb roux-en-Y gastrojejunostomy and intact papilla. Gastrointest Endosc. 2002;56(2):225–32.PubMedCrossRef
11.
go back to reference Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379–400.PubMedCrossRef Banks PA, Freeman ML. Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379–400.PubMedCrossRef
12.
go back to reference Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.PubMedCrossRef Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.PubMedCrossRef
13.
go back to reference Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–61. quiz–644.PubMedCrossRef Badalov N, Baradarian R, Iswara K, et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5(6):648–61. quiz–644.PubMedCrossRef
14.
go back to reference Brown A, Young B, Morton J, et al. Are health related outcomes in acute pancreatitis improving? An analysis of national trends in the U.S. from 1997 to 2003. JOP. 2008;9(4):408–14.PubMed Brown A, Young B, Morton J, et al. Are health related outcomes in acute pancreatitis improving? An analysis of national trends in the U.S. from 1997 to 2003. JOP. 2008;9(4):408–14.PubMed
15.
go back to reference Martinez J, Johnson CD, Sanchez-Paya J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6(3):206–9.PubMedCrossRef Martinez J, Johnson CD, Sanchez-Paya J, et al. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology. 2006;6(3):206–9.PubMedCrossRef
16.
go back to reference Hong S, Qiwen B, Ying J, et al. Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23(12):1136–43.PubMedCrossRef Hong S, Qiwen B, Ying J, et al. Body mass index and the risk and prognosis of acute pancreatitis: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23(12):1136–43.PubMedCrossRef
17.
go back to reference Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diabetes Rep. 2005;5(1):70–5.CrossRef Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diabetes Rep. 2005;5(1):70–5.CrossRef
18.
go back to reference Evans AC, Papachristou GI, Whitcomb DC. Obesity and the risk of severe acute pancreatitis. Minerva Gastroenterol Dietol. 2010;56(2):169–79.PubMed Evans AC, Papachristou GI, Whitcomb DC. Obesity and the risk of severe acute pancreatitis. Minerva Gastroenterol Dietol. 2010;56(2):169–79.PubMed
19.
go back to reference van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89(8):4062–8.PubMedCrossRef van Dielen FM, Buurman WA, Hadfoune M, et al. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab. 2004;89(8):4062–8.PubMedCrossRef
20.
go back to reference Uzun H, Zengin K, Taskin M, et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004;14(5):659–65.PubMedCrossRef Uzun H, Zengin K, Taskin M, et al. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004;14(5):659–65.PubMedCrossRef
21.
go back to reference Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618–24.PubMedCrossRef Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618–24.PubMedCrossRef
22.
go back to reference Morgan KA, Glenn JB, Byrne TK, et al. Sphincter of oddi dysfunction after roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(5):571–5.PubMedCrossRef Morgan KA, Glenn JB, Byrne TK, et al. Sphincter of oddi dysfunction after roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5(5):571–5.PubMedCrossRef
23.
go back to reference Woods CM, Mawe GM, Toouli J, et al. The sphincter of Oddi: understanding its control and function. Neurogastroenterol Motil. 2005;17 Suppl 1:31–40.PubMedCrossRef Woods CM, Mawe GM, Toouli J, et al. The sphincter of Oddi: understanding its control and function. Neurogastroenterol Motil. 2005;17 Suppl 1:31–40.PubMedCrossRef
Metadata
Title
Acute Pancreatitis in Patients After Bariatric Surgery: Incidence, Outcomes, and Risk Factors
Authors
Arthi Kumaravel
Andrea Zelisko
Philip Schauer
Rocio Lopez
Matthew Kroh
Tyler Stevens
Publication date
01-12-2014
Publisher
Springer US
Published in
Obesity Surgery / Issue 12/2014
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1337-4

Other articles of this Issue 12/2014

Obesity Surgery 12/2014 Go to the issue